Changes in intravenous and oral antimicrobial prescriptions during the coronavirus disease 2019 (COVID-19) pandemic: an experience at a tertiary-care center

Antimicrobial use during the coronavirus disease 2019 (COVID-19) pandemic at a tertiary-care center was analyzed using interrupted time-series analysis. Among intravenous antimicrobials, the use of azithromycin and third-generation cephalosporins significantly decreased during the current pandemic....

Descripción completa

Detalles Bibliográficos
Autores principales: Murakami, Shutaro, Takamatsu, Akane, Akazawa, Manabu, Goto, Takao, Miwa, Toshiki, Terayama, Yoshiyasu, Honda, Hitoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Concise Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726539/
https://www.ncbi.nlm.nih.gov/pubmed/36483370
http://dx.doi.org/10.1017/ash.2022.42
Descripción
Sumario:Antimicrobial use during the coronavirus disease 2019 (COVID-19) pandemic at a tertiary-care center was analyzed using interrupted time-series analysis. Among intravenous antimicrobials, the use of azithromycin and third-generation cephalosporins significantly decreased during the current pandemic. Similarly, the use of oral antimicrobials, including azithromycin and fluoroquinolones, also decreased.

Ejemplares similares